Thalidomide-NH-C6-NH2 TFA

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Thalidomide-NH-C6-NH2 TFA  纯度: 99.82%

Thalidomide-NH-C6-NH2 TFA是一种合成的 E3 连接酶配体 -linker 偶联物，包含基于 Thalidomide 的 cereblon 配体和 1 个 linker。

Thalidomide-NH-C6-NH2 TFA

Thalidomide-NH-C6-NH2 TFA Chemical Structure

CAS No. : 2093386-51-5

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
100 mg ￥5500 In-stock
250 mg ￥9800 In-stock
500 mg ￥13500 In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

生物活性

Thalidomide-NH-C6-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].

IC50 & Target

Cereblon

 

体外研究
(In Vitro)

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

486.44

Formula

C21H25F3N4O6
CAS 号

2093386-51-5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
参考文献

  • [1]. Wang Z, et al. Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands. J Med Chem. 2019 Sep 12;62(17):8152-8163.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务